Experience with amoxicillin: an overall summary of clinical trials in the United States.
D000284:Administration, Oral; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002214:Capsules; D002481:Cellulitis / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006069:Gonorrhea / Q000188:drug therapy; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D007169:Impetigo / Q000188:drug therapy; D008297:Male; D010033:Otitis Media / Q000188:drug therapy; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010612:Pharyngitis / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013535:Suspensions; D014481:United States; D014526:Urethritis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000588:Amines; D002214:Capsules; D010406:Penicillins; D013535:Suspensions